Memorial Sloan Kettering Cancer CenterDurability of CAR T-cell therapy response may depend on …Medical XpressAlthough most patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) experienced complete response after treatment with a type of… Continue reading
Medical XpressArtificial thymus can produce cancer-fighting T cells from blood stem cellsMedical XpressSince adoptive T cell immunotherapy was first used clinically in 2006, scientists have recognized that it would be more efficient to create a readily… Continue reading
Medical XpressArtificial thymus can produce cancer-fighting T cells from blood stem cellsMedical XpressSince adoptive T cell immunotherapy was first used clinically in 2006, scientists have recognized that it would be more efficient to create a readily… Continue reading
Synthego Awards Synthetic sgRNA Grant to University of Oxford for CRISPR Research Applications in the UKYahoo FinanceThe University of Oxford, selected for its novel research applications in bladder cancer, was one of eight institutions chosen for the … Continue reading
Hemophilia News TodayImprovements in Gene Therapy Carriers Key Step in Hemophilia Treatment DevelopmentHemophilia News TodayThe virus is unable to cause disease, and is a popular choice among researchers developing human gene therapies. But for the the… Continue reading
When will Korea reach diffusion points for stem cell and gene therapy technology?Korea Biomedical ReviewKorea will likely go ahead of Japan in reaching the diffusion point of stem cell technology but lags behind Japan in that of gene therapy, according… Continue reading
When will Korea reach diffusion points for stem cell and gene therapy technology?Korea Biomedical ReviewKorea will likely go ahead of Japan in reaching the diffusion point of stem cell technology but lags behind Japan in that of gene therapy, according… Continue reading
TechCrunchData Collective and SynBioBeta founder John Cumbers launch a seed stage biotech fundTechCrunchData Collective (DCVC) is bringing Dr. John Cumbers, the founder of synthetic biology platform SynBioBeta and setting him up with his own biotech fu… Continue reading